Novartis, Bayer and patent drafting: what’s on this week

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Novartis, Bayer and patent drafting: what’s on this week

Managing IP lists the IP events and lawsuits taking place this week



Tuesday August 21, 2012


The IP Office of the Philippines will be holding a course, Patent Drafting II, for examination passers only, location TBC

Hearing before India’s Intellectual Property Appellate Board in Natco v Bayer, concerning the compulsory license granted to Natco to manufacture generic versions of Bayer’s sorafenib.

Wednesday August 22


India’s Supreme Court is due to hear final arguments between Switzerland’s Novartis against India's patent office over its refusal to grant a patent over cancer drug Glivec.

The USPTO is seeking volunteers to test the new electronic filing system for administrative trials linked to post grant review, inter partes review and the transitional programme for covered business methods.

Friday August 24, 2012


The IP Office of the Philippines will be hosting a meeting with the Japan-Asia Young Scientist & Engineer Study (JAYSES) at its offices in Taguig City.

Last day of Apple v Samsung trial in California.



more from across site and ros bottom lb

More from across our site

Sources say they have found the social media platform Bluesky to be a good place to post IP content, while others plan to watch the site closely
The USPTO’s internal ban on AI use, a major SEP ruling rejecting an interim licence request, and the EUIPO’s five-year plan were among the biggest talking points
Speaking to Managing IP, Kathi Vidal says she’s looking forward to helping clients shape policy when she returns to Winston & Strawn
AA Thornton and Venner Shipley’s combination creates a new kid on the block, but one which could rival the major UPC players
Amit Aswal explains why you should take on challenges early in your career and why the IP community is a strong, trustworthy network
Five members of Qantm’s leadership team, including its new managing director, discuss how the business is operating under private equity ownership and reveal expansion plans
In our latest UPC update, we examine an important decision concerning the withdrawal of opt-outs, a significant victory for Edwards, and the launch of a new Hamburg-based IP firm
The combined firm, which will operate under the Venner Shipley name and have 46 partners, will go live in December
Vidal, who recently announced her departure from the USPTO, said she decided to rejoin the firm because of its team and culture
Osborne Clarke said John Linneker’s experience, including acting for SkyKick in the seminal dispute with Sky, will be a huge asset to the firm
Gift this article